- Research works
- 104 ▼ 37% vs 2013–17
- Citations
- 2.6k 25.3 per fractional work
- Top-10% rate
- 50.1% record average 16.5%
- Open access
- 36% world 28%
Not ranked overall: Pfizer (Belgium) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 23.3×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 23.3×
- Biochemistry, Genetics and Molecular Biology 4.1×
- Immunology and Microbiology 3.3×
- Economics, Econometrics and Finance 3.2×
- Medicine 1.9×
- Health Professions 1.2×
- Mathematics 1.0×
- Engineering 0.8×
- Neuroscience 0.7×
- Chemistry 0.6×
- Decision Sciences 0.4×
- Materials Science 0.3×
- Social Sciences 0.2×
- Computer Science 0.1×
Which keywords describe research at Pfizer (Belgium)?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Inflammation, Liquid Chromatography, Chiral Separation, Gas Chromatography, Antimicrobial Resistance, Cardiovascular Risk and Autoantibodies.
- Normalization
- Pharmacokinetics
- Breast Cancer
- Pastoralists
- Data Analysis
- Vaccine Development
- Therapeutic Antibodies
- Drug Resistance
- Biopharmaceuticals
- Pathogenesis
- Biological Therapy
- Biomedical Research
- Rheumatoid Arthritis
- Lab-on-a-Chip
- Immune Response
- Clinical Trials
- Treatment
- Chiral Separation
- Antimicrobial Resistance
- Inflammation
- Epidemiology
- Liquid Chromatography
- Cardiovascular Risk
- Gas Chromatography
- Autoantibodies
- Vaccine
- Cytokines
- Monoclonal Antibodies
- Point-of-Care Diagnostics
- Poly(dimethylsiloxane)
- Disease-Modifying Antirheumatic Drugs
- Antiretroviral Therapy
- Immunogenicity
- Genetic Variation
- Vaccination
- Community-Acquired Pneumonia
- Pneumococcal Conjugate Vaccine
- Rangeland Degradation
- Medication Adherence
- Immunocompromised Patients
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology13▲ 3.2×46 topics
- Inflammation7▲ 3.0×19 topics
- Liquid Chromatography4▲ 29×2 topics
- Antimicrobial Resistance4▲ 16×7 topics
- Cardiovascular Risk4▲ 11×6 topics
- Chiral Separation4▲ 33×1 topic
- Gas Chromatography4▲ 33×1 topic
- Treatment4▲ 2.8×12 topics
- Autoantibodies4▲ 15×5 topics
- Clinical Trials4▲ 5.7×10 topics
- Vaccine4▲ 8.6×9 topics
- Immune Response3▲ 5.3×10 topics
- Cytokines3▲ 12×2 topics
- Lab-on-a-Chip3▲ 23×3 topics
- Monoclonal Antibodies3▲ 22×3 topics
- Rheumatoid Arthritis3▲ 31×2 topics
- Point-of-Care Diagnostics3▲ 36×2 topics
- Biomedical Research3▲ 40×1 topic
- Poly(dimethylsiloxane)3▲ 62×1 topic
- Biological Therapy3▲ 52×1 topic
- Disease-Modifying Antirheumatic Drugs3▲ 59×1 topic
- Pathogenesis3▲ 5.2×11 topics
- Antiretroviral Therapy3▲ 12×5 topics
- Biopharmaceuticals2▲ 35×2 topics
- Immunogenicity2▲ 46×2 topics
- Drug Resistance2▲ 7.2×5 topics
- Genetic Variation2▲ 6.8×3 topics
- Therapeutic Antibodies2▲ 16×2 topics
- Vaccination2▲ 28×2 topics
- Vaccine Development2▲ 6.9×5 topics
- Community-Acquired Pneumonia2▲ 49×1 topic
- Data Analysis2▲ 6.2×3 topics
- Pneumococcal Conjugate Vaccine2▲ 49×1 topic
- Pastoralists2▲ 78×1 topic
- Rangeland Degradation2▲ 78×1 topic
- Breast Cancer2▲ 6.4×6 topics
- Medication Adherence2▲ 31×2 topics
- Pharmacokinetics2▲ 6.8×5 topics
- Immunocompromised Patients2▲ 25×2 topics
- Normalization2▲ 24×2 topics
Which research topics does Pfizer (Belgium) publish most on?
By volume in 2022–2025: Drug Solubulity and Delivery Systems, Health Systems, Economic Evaluations, Quality of Life, Protein purification and stability and HIV/AIDS drug development and treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Drug Solubulity and Delivery Systems Pharmaceutical Science 0 works
- 2 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
- 3 Protein purification and stability Molecular Biology 0 works
- 4 HIV/AIDS drug development and treatment Infectious Diseases 0 works
- 5 Pharmacogenetics and Drug Metabolism Pharmacology 0 works
- 6 Metallurgy and Material Forming Mechanics of Materials 0 works
- 7 Pharmaceutical Economics and Policy Economics and Econometrics 0 works
- 8 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
- 9 Growth Hormone and Insulin-like Growth Factors Endocrinology, Diabetes and Metabolism 0 works
- 10 Biosimilars and Bioanalytical Methods Immunology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Pfizer (Belgium)'s research output changed?
Output in 2018–2022 was 37% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Brussels
- Vrije Universiteit Brussel
- Université Libre de Bruxelles
- Cliniques Universitaires Saint-Luc
- Erasmus Hospital
- European Commission
- UCLouvain Saint-Louis Brussels
- European Union of Medical Specialists
- European Union
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.